Umbilical vein injection for retained placenta: clinical feasibility study of a new technique.
Intraumbilical oxytocin infusion for retained placenta is a relatively new and promising technique. We have tested the clinical feasibility of different infusion techniques in this study. Nine patients had intraumbilical infusions through a mucus aspiration catheter and 12 by an 18 gauge needle. Infusion was successful in 7(77.7%) of 9 cases following catheterisation and in 7(58.3%) of 12 cases following direct injection. Both techniques were clinically feasible, but direct injection was somewhat easier than catheterisation. The importance of non-operative management of retained placenta, particularly in areas with limited medical facilities, is discussed and an approach to the management of retained placenta proposed.
Pipingas
A
A
Department of Obstetrics and Gynaecology, Coronation/JG Strijdom Hospital, Baragwanath, South Africa.
Gulmezoglu
A M
AM
Mitri
F F
FF
Hofmeyr
G J
GJ
D000328:Adult; D002408:Catheters, Indwelling; D002985:Clinical Protocols; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000295:instrumentation / Q000379:methods*; D009339:Needles; D010121:Oxytocin / Q000627:therapeutic use*; D018457:Placenta, Retained / Q000188:drug therapy*; D011247:Pregnancy; D013997:Time Factors; D014143:Traction; D016896:Treatment Outcome; D014471:Umbilical Veins
D010121:Oxytocin